Antonella M Borgatti

20052020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 9 Similar Profiles
Dogs Medicine & Life Sciences
dogs Agriculture & Biology
Canidae Medicine & Life Sciences
drug therapy Agriculture & Biology
lymphoma Agriculture & Biology
Lymphoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2009 2020

Research Output 2005 2019

Use of computed tomography and radiation therapy planning software to develop a novel formula for body surface area calculation in dogs

Girens, R., Bukoski, A., Maitz, C. A., Boston, S. E., Borgatti, A. M., Sprinkle, M., Orrego, D., Kesl, S. & Selting, K., Mar 1 2019, In : Journal of veterinary internal medicine. 33, 2, p. 792-799 8 p.

Research output: Contribution to journalArticle

Open Access
Body Surface Area
radiotherapy
computed tomography
surface area
Radiotherapy
2 Citations (Scopus)

Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma

Sadowski, A. R., Gardner, H. L., Borgatti, A. M., Wilson, H., Vail, D. M., Lachowicz, J., Manley, C., Turner, A., Klein, M. K., Waite, A., Sahora, A. & London, C. A., Aug 24 2018, In : BMC Veterinary Research. 14, 1, 250.

Research output: Contribution to journalArticle

Cell Nucleus Active Transport
lymphoma
mouth
Lymphoma
Dogs
Open Access
Rhabdomyosarcoma
Osteosarcoma
Epidermal Growth Factor Receptor
Adenocarcinoma
Ligands
4 Citations (Scopus)

Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors

Pilbeam, K., Wang, H., Taras, E., Bergerson, R. J., Ettestad, B., De For, T. E., Borgatti, A. M., Vallera, D. A. & Verneris, M. R., Jan 1 2018, In : Oncotarget. 9, 15, p. 11938-11947 10 p.

Research output: Contribution to journalArticle

Immunotoxins
Urokinase-Type Plasminogen Activator
Sarcoma
Plasminogen Activators
Pediatrics
1 Citation (Scopus)

A double blinded, placebo-controlled pilot study to examine reduction of CD34+/CD117+/CD133+ lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma

Modiano, J., Ito, D., Childress, M., Mason, N., Winter, A., O'Brien, T. D., Henson, M. S., Borgatti, A. M., Lewellen, M., Krick, E., Stewart, J., Lahrman, S., Rajwa, B., Scott, M. C., Seelig, D., Koopmeiners, J. & Ruetz, S., Jan 1 2017, In : F1000Research. 4, 42.

Research output: Contribution to journalArticle

Open Access
Lymphoid Progenitor Cells
B-Cell Lymphoma
Lymphoma
Stem Cells
Placebos